Métastase surranélienne : survie après chirurgie d’exérèse

Kapella, M.; Genet, Dominique; Laclause, B Pech de; Durand-Fontanier, Sylvaine; Lachachi, Meriem; Fabre, Aurélie; Valleix, D.; Descottes, B

doi:10.1016/s0021-7697(08)74314-x

Cited by 6 publications

(3 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, in our investigation, all of patients with CRC adrenal metastasis had a median survival time of 38.2 months after complete removal of the metastatic cancer; among the 13 patients, 3 survived for nearly 5 years. Patients who underwent surgical treatment had better survival than those who received nonsurgical treatments for adrenal metastasis [ 6 ]. Therefore, we believe that, in patients who have a single site of metastasis along with primary cancer that is under control and who are physically amenable to enduring surgery, surgical treatment can lead to long-term benefits.…”

Section: Discussionmentioning

confidence: 99%

Clinical analysis of 13 colorectal cancer patients with adrenal metastasis and a brief literature review

Chen,

Tan,

Chen

et al. 2023

Gastroenterology Report

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Clinical analysis of 13 colorectal cancer patients with adrenal metastasis and a brief literature review

Chen,

Tan,

Chen

et al. 2023

Gastroenterology Report

View full text Add to dashboard Cite

“…Although adrenalectomy for metastatic gastric cancer has not been widely performed, surgical resection has been adopted in many more cases, particularly in cases of lung cancer and renal cell carcinoma [11,12]. In general, adrenalectomy for a metastatic tumors is associated with a poor prognosis: The overall 5-year survival rate is 13% to 29%, and the median survival time is 13 to 28 months [12,13].…”

Section: Discussionmentioning

confidence: 99%

Surgical treatment for late-appearing adrenal metastasis from gastric cancer: report of two cases

2014

View full text Add to dashboard Cite

Adrenal metastasis following gastrectomy for gastric cancer is often encountered as part of advanced systemic dissemination, which is usually unresectable. Thus, there are very few published case reports describing metastasectomy for adrenal metastasis from gastric cancer. Herein we present our experience in treating two patients diagnosed and treated for adrenal metastasis 6 years following initial surgery for advanced gastric cancer (pT2bN1M0 and pT2bN0M0, respectively, according to the classification system set forth in the sixth edition of The TNM Classification of Malignant Tumours by the International Union against Cancer). They underwent successful en bloc R0 resections, followed by systemic chemotherapy with close postoperative follow-up for another recurrence, and have remained alive without recurrence for 1 year. These results suggest that active surgical treatment for resectable metastatic gastric cancer in the adrenal glands has an important role in prolonging survival in selected patients.

show abstract

“…Theincidenceofsolitaryadrenalmetastasesislow,ranging from1to6% [4][5][6].Managementofthesepatientsiscontroversial,andtheroleofsurgeryhasbeenquestionedduetothe highincidenceofsubsequentsystemicprogression.Theoutcomes of these patients vary across larger series involving 10ormorepatients,withmediansurvivalrangingfrom11to 31months [7][8][9][10][11][12][13].Limiteddataonfavourableprognosticfactorsresultinginimprovedoutcomesaftersurgeryisavailable intheliterature.Inordertohelpcliniciansintheirtreatment decisions,weanalysedtreatmentoutcomesofpatientstreated withadrenalectomyforsolitarymetastasesatourcentreand reviewedtheavailableliterature.…”

Section: Thepatientcharacteristicsaresummarisedindetailintable1mentioning

confidence: 99%

Surgical Resection of Isolated Adrenal Metastases in Patients with Non-Small Cell Lung Cancer: A Single-Institution Experience and Review of the Literature

Bastian¹,

Clerici²,

Neuweiler

et al. 2011

Onkologie

View full text Add to dashboard Cite

Background: In non-small cell lung cancer (NSCLC), the benefits of resection of solitary adrenal metastases for survival and the identification of patients most likely to benefit from adrenalectomy are unknown. Patients and Methods: We retrospectively reviewed clinico-pathological factors and outcomes in 4 NSCLC patients treated with adrenalectomy at our centre. We reviewed the published literature with a focus on long-term survivors in order to formulate treatment recommendations. Results: Local pathological staging showed stages IA–IIA. All had a performance status (PS) of 0. The median age was 56 years (range: 53–58 years). Adrenal metastases were detected by positron emission tomography-computed tomography (PET-CT) in 3 patients. Median time from lobectomy to occurrence of metachronous adrenal metastases was 12.3 months (11–14 months). The perioperative mortality was zero. All patients recurred systemically after adrenalectomy within 2–49 months. 3 patients died due to systemic progression 6–15 months after adrenalectomy. 1 patient is alive with pulmonary relapse 49 months after adrenalectomy. Conclusions: Resection of solitary adrenal metastases in selected good-PS NSCLC patients with minimal local nodal involvement from the primary tumour is associated with low morbidity and may offer a chance for long-term disease-free survival in a small subset of patients. Careful pre-operative staging including PET-CT is warranted.

show abstract

Métastase surranélienne : survie après chirurgie d’exérèse

Cited by 6 publications

References 31 publications

Clinical analysis of 13 colorectal cancer patients with adrenal metastasis and a brief literature review

Clinical analysis of 13 colorectal cancer patients with adrenal metastasis and a brief literature review

Surgical treatment for late-appearing adrenal metastasis from gastric cancer: report of two cases

Surgical Resection of Isolated Adrenal Metastases in Patients with Non-Small Cell Lung Cancer: A Single-Institution Experience and Review of the Literature

Contact Info

Product

Resources

About